Literature DB >> 10853849

Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release.

G I Criqui1, C Solomon, B S Welch, R E Ferrando, H A Boushey, J R Balmes.   

Abstract

Exposure of humans to ozone causes increased neutrophils and inflammatory cytokines in airway lining fluid. Recent research shows that macrolide antibiotics may reduce interleukin (IL)-8 production by bronchial epithelial cells and inhibit neutrophil chemotaxis. A double-blind, cross-over study was performed in which 12 healthy subjects underwent two separate 4-h exposures to 0.2 parts per million ozone while exercising intermittently. In the 73.5 h before exposure, subjects were pretreated with either 1,250 mg azithromycin or placebo. Sputum induction conducted 74 h pre- and 18 h post-exposure was used to measure total cells, per cent neutrophils, IL-6, and IL-8. There were significant (p<0.05) pre- to post-exposure increases in total cells, neutrophils, IL-6 and IL-8 in both the azithromycin and placebo arms. However, no significant differences were found between azithromycin and placebo conditions in the post- minus pre-exposure value for these variables. The results suggest that in healthy subjects, in the design used, azithromycin, in usual clinical doses, does not have anti-inflammatory effects on human airways as indicated in the measured variables.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10853849     DOI: 10.1034/j.1399-3003.2000.15e08.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Inhibition of myristoylated alanine-rich C kinase substrate (MARCKS) protein inhibits ozone-induced airway neutrophilia and inflammation.

Authors:  Gautam Damera; William F Jester; Meiqi Jiang; Hengjiang Zhao; Homer W Fogle; Michael Mittelman; Angela Haczku; Edwin Murphy; Indu Parikh; Reynold A Panettieri
Journal:  Exp Lung Res       Date:  2010-03       Impact factor: 2.459

Review 2.  Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Authors:  P M Bartold; A H du Bois; S Gannon; D R Haynes; R S Hirsch
Journal:  Inflammopharmacology       Date:  2013-02-28       Impact factor: 4.473

Review 3.  Modification by antioxidant supplementation of changes in human lung function associated with air pollutant exposure: a systematic review.

Authors:  Amir Y Tashakkor; Katherine S Chow; Chris Carlsten
Journal:  BMC Public Health       Date:  2011-07-05       Impact factor: 3.295

4.  The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms.

Authors:  Petra Zimmermann; Victoria C Ziesenitz; Nigel Curtis; Nicole Ritz
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

Review 5.  Azithromycin through the Lens of the COVID-19 Treatment.

Authors:  Georgia G Kournoutou; George Dinos
Journal:  Antibiotics (Basel)       Date:  2022-08-05

6.  Azithromycin inhibits mucus hypersecretion from airway epithelial cells.

Authors:  Takeshi Shimizu; Shino Shimizu
Journal:  Mediators Inflamm       Date:  2012-04-23       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.